广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | TSVT | 2seventy bio Inc | 2.29 | 0.01% |
| 2024-12-31 | TCRX | TScan Therapeutics Inc | 2.25 | 0.01% |
| 2024-12-31 | BMEA | Biomea Fusion Inc | 2.19 | 0.01% |
| 2024-12-31 | KYTX | Kyverna Therapeutics Inc | 2.44 | 0.01% |
| 2024-12-31 | CLYM | Climb Bio Inc | 1.83 | 0.01% |
| 2024-12-31 | PEPG | PepGen Inc | 1.86 | 0.01% |
| 2024-12-31 | ENTA | Enanta Pharmaceuticals Inc | 1.84 | 0.01% |
| 2024-12-31 | STRO | Sutro Biopharma Inc | 2.29 | 0.01% |
| 2024-12-31 | EDIT | Editas Medicine Inc | 1.67 | 0.01% |
| 2024-12-31 | QTTB | Q32 Bio Inc | 0.63 | 0% |
| 2024-12-31 | SGYP | Synergy Pharmaceuticals Inc | 0.02 | 0% |
| 2024-12-31 | AKAO | Achaogen Inc | 0.03 | 0% |
| 2024-12-31 | SNNA | 西恩纳生物医药 | 0 | 0% |
| 2024-12-31 | EVLO | Evelo Biosciences Inc | 0 | 0% |
| 2024-09-30 | GILD | 吉利德科学 | 1518.22 | 8.41% |
| 2024-09-30 | REGN | 再生元制药 | 1247.88 | 6.91% |
| 2024-09-30 | AMGN | 安进 | 1226.01 | 6.79% |
| 2024-09-30 | VRTX | 福泰制药 | 1188.88 | 6.59% |
| 2024-09-30 | AZN | 阿斯利康(US ADR) | 581.11 | 3.22% |
| 2024-09-30 | ALNY | Alnylam Pharmaceuticals Inc | 545.6 | 3.02% |
公告&资料
